AC Immune

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AC Immune and other ETFs, options, and stocks.

About ACIU

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. 

CEO
Andrea Pfeifer
CEOAndrea Pfeifer
Employees
122
Employees122
Headquarters
Lausanne, Vaud
HeadquartersLausanne, Vaud
Founded
2003
Founded2003
Employees
122
Employees122

ACIU Key Statistics

Market cap
341.95M
Market cap341.95M
Price-Earnings ratio
-4.05
Price-Earnings ratio-4.05
Dividend yield
Dividend yield
Average volume
298.86K
Average volume298.86K
High today
$3.44
High today$3.44
Low today
$3.33
Low today$3.33
Open price
$3.40
Open price$3.40
Volume
156.45K
Volume156.45K
52 Week high
$4.00
52 Week high$4.00
52 Week low
$1.45
52 Week low$1.45

Stock Snapshot

AC Immune(ACIU) stock is priced at $3.36, giving the company a market capitalization of 341.95M. It carries a P/E multiple of -4.05.

During the trading session on 2026-04-10, AC Immune(ACIU) shares reached a daily high of $3.44 and a low of $3.33. At a current price of $3.36, the stock is +0.9% higher than the low and still -2.3% under the high.

Trading volume for AC Immune(ACIU) stock has reached 156.45K, versus its average volume of 298.86K.

The stock's 52-week range extends from a low of $1.45 to a high of $4.00.

The stock's 52-week range extends from a low of $1.45 to a high of $4.00.

ACIU News

The Motley Fool 3d
Why AC Immune Stock Zoomed Almost 15% Higher Today

AC Immune (ACIU +15.19%) isn't a familiar name to many investors, but that might be changing. The Switzerland-based biotech saw its stock zoom nearly 15% skywar...

Why AC Immune Stock Zoomed Almost 15% Higher Today
TipRanks 3d
Leerink calls AC Immune- Eli Lilly Tau amendment ‘great news’

Leerink analyst Marc Goodman says AC Immune’s (ACIU) amendment of the collaboration agreement with Eli Lilly (LLY) for the Morphomer Tau program is “great news”...

Nasdaq 3d
AC Immune Amends Morphomer Tau Agreement With Lilly

(RTTNews) - AC Immune SA (ACIU) said Tuesday it has agreed with Eli Lilly and Company (LLY) to amend their 2018 license and collaboration agreement to advance T...

AC Immune Amends Morphomer Tau Agreement With Lilly

More ACIU News

TipRanks 3d
AC Immune Secures Amended Tau Drug Collaboration with Lilly, Adds CHF 10 Million Upfront

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

People also own

Based on the portfolios of people who own ACIU. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.